title: Inflammatory carcinoma of the breast.
abstract: Inflammatory breast carcinoma has to be defined by accurate clinical and pathological criteria. The prognosis is very poor and improvements made by chemotherapy are limited to the increase in the disease-free period and overall survival for a few months.
authors.affiliation: Service de Gynécologie Obstétrique A, Hopital de la Conception.
authors.forename: P
authors.initials: P
authors.lastname: Bonnier
authors.forename: L
authors.initials: L
authors.lastname: Piana
authors.forename: A
authors.initials: A
authors.lastname: Khouzami
authors.forename: S
authors.initials: S
authors.lastname: Romain
authors.forename: J
authors.initials: J
authors.lastname: Padaut
authors.forename: C
authors.initials: C
authors.lastname: Charpin
authors.forename: H
authors.initials: H
authors.lastname: Vacheret
authors.forename: J
authors.initials: J
authors.lastname: Jacquemier
authors.forename: N
authors.initials: N
authors.lastname: Tubiana
authors.forename: C
authors.initials: C
authors.lastname: Lejeune
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D002277:Carcinoma / Q000473:pathology* / Q000556:secondary / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D016019:Survival Analysis